1. Home
  2. ZYME vs NOMD Comparison

ZYME vs NOMD Comparison

Compare ZYME & NOMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Zymeworks Inc.

ZYME

Zymeworks Inc.

HOLD

Current Price

$22.88

Market Cap

1.8B

Sector

Health Care

ML Signal

HOLD

Logo Nomad Foods Limited

NOMD

Nomad Foods Limited

HOLD

Current Price

$9.84

Market Cap

1.4B

ML Signal

HOLD

Company Overview

Basic Information
Metric
ZYME
NOMD
Founded
2003
2014
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Packaged Foods
Sector
Health Care
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
1.4B
IPO Year
2022
2015

Fundamental Metrics

Financial Performance
Metric
ZYME
NOMD
Price
$22.88
$9.84
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
11
4
Target Price
$38.90
$14.25
AVG Volume (30 Days)
630.3K
1.8M
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
7.12%
EPS Growth
33.33
N/A
EPS
N/A
N/A
Revenue
$105,965,000.00
N/A
Revenue This Year
$162.82
N/A
Revenue Next Year
N/A
$0.36
P/E Ratio
N/A
$8.38
Revenue Growth
38.87
N/A
52 Week Low
$9.03
$9.54
52 Week High
$28.49
$20.14

Technical Indicators

Market Signals
Indicator
ZYME
NOMD
Relative Strength Index (RSI) 43.81 24.74
Support Level $22.23 N/A
Resistance Level $23.66 $12.36
Average True Range (ATR) 1.42 0.41
MACD -0.05 -0.15
Stochastic Oscillator 9.06 8.45

Price Performance

Historical Comparison
ZYME
NOMD

About ZYME Zymeworks Inc.

Zymeworks Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialization of next-generation multifunctional biotherapeutics. Its suite of therapeutic platforms and its fully integrated drug development engine enables precise engineering of differentiated therapeutic product candidates. Its clinical candidate, zanidatamab, is a novel HER2-targeted bispecific antibody currently being evaluated in multiple Phase 1, Phase 2, and pivotal clinical trials globally as a targeted treatment option for patients with solid tumors that express HER2. The company is also advancing a deep preclinical pipeline in oncology and other therapeutic areas.

About NOMD Nomad Foods Limited

Nomad Foods Ltd is a packaged foods company that is involved in the business of manufacturing and distributing branded frozen foods in Western Europe. The company manufactures and markets frozen food products such as fish, vegetables, poultry, Ice Cream, and ready meals like pizza. It sells its products through large grocery retailers under the brand Birds Eye in the United Kingdom and Ireland, Findus in Italy, France, Spain, and Iglo in Germany and other continental markets. The company operates through a single segment being Frozen. The majority of the revenue is generated from the United Kingdom.

Share on Social Networks: